[1]
Srilar, P., Ramart, P., Nualyong, C., Soontrapa, S., Sujijantararat, P., Leewansangtong, S., Srinualnad, S., Taweemonkongsap, T., Chaiyaprasithi, B., Amornvesukit, T. and Phinthusophon, K. 2012. Comparison of 1 Year Recurrent Rate in High-Risk of Recurrent Non-Muscle Invasive Bladder Cancer Who Had Received Induction Course of Intravesical BCG after TUR-BT Between Combination with Immediate Intravesical Mitomycin C and Induction Course of Intrave. Insight Urology. 33, 1 (Jun. 2012), 34–42.